IRIS Registry study reveals decline in bevacizumab use

• Posted on: May 25 2021
• By: Saratoga Opthalmology
• Leave a response

This IRIS Registry study assessed use of bevacizumab among patients with Medicare fee-for-service health insurance between 2013 and 2019.
Source: AAO

Posted in: Uncategorized